Abeona Therapeutics Inc vs Tapestry, Inc. — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Tapestry, Inc. trades at $161 (market cap $32.44B). The key difference: Tapestry, Inc. is far larger — about 77× Abeona Therapeutics Inc's market cap, and Tapestry, Inc. pays a 1% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | TPR | |
|---|---|---|
Market Cap | $421.19M | $32.44B |
Sector | Health | Consumer Cyclical |
52-Week High | $7.45 | $164.78 |
52-Week Low | $4.17 | $95.69 |
Enterprise Value | $276.10M | $35.29B |
Dividend Yield | — | 1% |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Coach, Kate Spade, and Stuart Weitzman are the fashion and accessory brands that comprise Tapestry. The firm's products are sold through about 1,400 company-operated stores, wholesale channels, and e-commerce in North America (67% of fiscal 2022 sales), Europe, Asia (28% of fiscal 2022 sales), and elsewhere. Coach (74% of fiscal 2022 sales) is best known for affordable luxury leather products. Kate Spade (22% of fiscal 2022 sales) is known for colorful patterns and graphics. Women's handbags and accessories produced 69% of Tapestry's sales in fiscal 2022. Stuart Weitzman, Tapestry's smallest brand, generates nearly all its revenue from women's footwear.
Read more on TPR →